Capstone Investment Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.36M | Buy |
7,100
+2,700
| +61% | +$1.36M | 0.01% | 509 |
|
|
2025
Q4 | $2.05M | Sell |
4,400
-3,600
| -45% | -$1.67M | ﹤0.01% | 617 |
|
|
2025
Q3 | $3.41M | Buy |
8,000
+1,200
| +18% | +$465K | 0.01% | 587 |
|
|
2025
Q2 | $2.61M | Sell |
6,800
-1,200
| -15% | -$432K | 0.01% | 562 |
|
|
2025
Q1 | $2.76M | Sell |
8,000
-21,800
| -73% | -$7.01M | 0.01% | 602 |
|
|
2024
Q4 | $8.94M | Buy |
29,800
+6,500
| +28% | +$2.27M | 0.02% | 377 |
|
|
2024
Q3 | $9.47M | Buy |
23,300
+900
| +4% | +$330K | 0.03% | 309 |
|
|
2024
Q2 | $7.2M | Buy |
22,400
+6,600
| +42% | +$2.14M | 0.02% | 367 |
|
|
2024
Q1 | $5.27M | Sell |
15,800
-12,900
| -45% | -$3.94M | 0.02% | 420 |
|
|
2023
Q4 | $7.77M | Buy |
28,700
+10,400
| +57% | +$2.57M | 0.02% | 400 |
|
|
2023
Q3 | $4.5M | Buy |
18,300
+5,800
| +46% | +$1.59M | 0.02% | 460 |
|
|
2023
Q2 | $3.79M | Hold |
12,500
| – | – | 0.02% | 459 |
|
|
2023
Q1 | $3.3M | Sell |
12,500
-50,600
| -80% | -$12.9M | 0.02% | 462 |
|
|
2022
Q4 | $15.1M | Buy |
63,100
+1,200
| +2% | +$269K | 0.11% | 158 |
|
|
2022
Q3 | $11.4M | Sell |
61,900
-4,000
| -6% | -$797K | 0.07% | 207 |
|
|
2022
Q2 | $11.1M | Sell |
65,900
-72,800
| -52% | -$15.6M | 0.05% | 239 |
|
|
2022
Q1 | $34.8M | Sell |
138,700
-147,700
| -52% | -$37.1M | 0.1% | 160 |
|
|
2021
Q4 | $73.6M | Buy |
286,400
+48,800
| +21% | +$11.9M | 0.12% | 139 |
|
|
2021
Q3 | $57.7M | Buy |
237,600
+24,000
| +11% | +$5.87M | 0.11% | 156 |
|
|
2021
Q2 | $44.2M | Buy |
213,600
+76,300
| +56% | +$15.6M | 0.1% | 178 |
|
|
2021
Q1 | $25.9M | Buy |
137,300
+34,600
| +34% | +$6.1M | 0.08% | 240 |
|
|
2020
Q4 | $16.9M | Buy |
102,700
+14,600
| +17% | +$2.13M | 0.06% | 280 |
|
|
2020
Q3 | $11M | Buy |
88,100
+19,600
| +29% | +$2.43M | 0.06% | 302 |
|
|
2020
Q2 | $6.65M | Buy |
68,500
+11,300
| +20% | +$1.17M | 0.04% | 349 |
|
|
2020
Q1 | $5.14M | Sell |
57,200
-42,400
| -43% | -$5.49M | 0.08% | 266 |
|
|
2019
Q4 | $14.7M | Buy |
99,600
+21,600
| +28% | +$2.9M | 0.08% | 257 |
|
|
2019
Q3 | $9.39M | Buy |
78,000
+13,900
| +22% | +$1.8M | 0.06% | 297 |
|
|
2019
Q2 | $8.66M | Buy |
64,100
+18,900
| +42% | +$2.39M | 0.06% | 331 |
|
|
2019
Q1 | $5.89M | Buy |
45,200
+19,600
| +77% | +$2.63M | 0.05% | 316 |
|
|
2018
Q4 | $3.19M | Buy |
25,600
+9,900
| +63% | +$1.33M | 0.04% | 349 |
|
|
2018
Q3 | $2.18M | Buy |
+15,700
| New | +$1.95M | 0.02% | 413 |
|
|
2015
Q1 | – | Sell |
-12,500
| Closed | -$917K | – | 301 |
|
|
2014
Q4 | $917K | Hold |
12,500
| – | – | 0.01% | 269 |
|
|
2014
Q3 | $881K | Buy |
+12,500
| New | +$826K | 0.01% | 343 |
|
Other funds holding HCA
VCM
VPM
Capstone Investment Advisors's HCA Position: Q1 2026 in Review
Capstone Investment Advisors opened a new position in HCA Healthcare (HCA) in Q1 2026: 442 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1509 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in HCA as recently as Q1 2025.
Capstone Investment Advisors first reported a position in HCA in Q2 2017 and has held it in 22 quarters since. The position peaked at $7.06M in Q3 2022. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Capstone Investment Advisors held 442 shares of HCA Healthcare worth $209K as of Q1 2026.
- HCA Healthcare was a new Capstone Investment Advisors position in Q1 2026.
- HCA Healthcare made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1509 holding.
- Capstone Investment Advisors first reported a position in HCA Healthcare in Q2 2017 and has held it in 22 quarters since.
- Capstone Investment Advisors's HCA Healthcare position peaked at $7.06M in Q3 2022.
- 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.